These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38343232)

  • 1. CT-Based Radiomics and Machine Learning for Differentiating Benign, Borderline, and Early-Stage Malignant Ovarian Tumors.
    Chen J; Liu L; He Z; Su D; Liu C
    J Imaging Inform Med; 2024 Feb; 37(1):180-195. PubMed ID: 38343232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-based radiomics analysis of different machine learning models for differentiating benign and malignant parotid tumors.
    Zheng Y; Zhou D; Liu H; Wen M
    Eur Radiol; 2022 Oct; 32(10):6953-6964. PubMed ID: 35484339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-based deep learning radiomics model for differentiating benign, borderline, and malignant ovarian tumours: a multi-class classification exploratory study.
    Du Y; Guo W; Xiao Y; Chen H; Yao J; Wu J
    BMC Med Imaging; 2024 Apr; 24(1):89. PubMed ID: 38622546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.
    Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
    Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial salivary gland tumors: Utility of radiomics analysis based on diffusion-weighted imaging for differentiation of benign from malignant tumors.
    Shao S; Mao N; Liu W; Cui J; Xue X; Cheng J; Zheng N; Wang B
    J Xray Sci Technol; 2020; 28(4):799-808. PubMed ID: 32538891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Contrasted CT Radiomics for SAH Prognosis Prediction.
    Shan D; Wang J; Qi P; Lu J; Wang D
    Bioengineering (Basel); 2023 Aug; 10(8):. PubMed ID: 37627852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors.
    Liu X; Wang T; Zhang G; Hua K; Jiang H; Duan S; Jin J; Zhang H
    J Ovarian Res; 2022 Feb; 15(1):22. PubMed ID: 35115022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine-learning-based contrast-enhanced computed tomography radiomic analysis for categorization of ovarian tumors.
    Li J; Zhang T; Ma J; Zhang N; Zhang Z; Ye Z
    Front Oncol; 2022; 12():934735. PubMed ID: 36016613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning for differentiation of lipid-poor adrenal adenoma and subclinical pheochromocytoma based on multiphase CT imaging radiomics.
    Xiao DX; Zhong JP; Peng JD; Fan CG; Wang XC; Wen XL; Liao WW; Wang J; Yin XF
    BMC Med Imaging; 2023 Oct; 23(1):159. PubMed ID: 37845636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A radiomics approach for automated diagnosis of ovarian neoplasm malignancy in computed tomography.
    Li S; Liu J; Xiong Y; Pang P; Lei P; Zou H; Zhang M; Fan B; Luo P
    Sci Rep; 2021 Apr; 11(1):8730. PubMed ID: 33888749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid ultrasound morphology.
    Moro F; Vagni M; Tran HE; Bernardini F; Mascilini F; Ciccarone F; Nero C; Giannarelli D; Boldrini L; Fagotti A; Scambia G; Valentin L; Testa AC
    Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38748935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a combined radiomics nomogram based on CE-CT in the preoperative prediction of thymomas risk categorization.
    Dong W; Xiong S; Lei P; Wang X; Liu H; Liu Y; Zou H; Fan B; Qiu Y
    Front Oncol; 2022; 12():944005. PubMed ID: 36081562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
    Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
    EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiphasic CT-Based Radiomics Analysis for the Differentiation of Benign and Malignant Parotid Tumors.
    Yu Q; Wang A; Gu J; Li Q; Ning Y; Peng J; Lv F; Zhang X
    Front Oncol; 2022; 12():913898. PubMed ID: 35847942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
    Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
    Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based radiomics analysis for differentiating phyllodes tumors of the breast from fibroadenomas.
    Tsuchiya M; Masui T; Terauchi K; Yamada T; Katyayama M; Ichikawa S; Noda Y; Goshima S
    Eur Radiol; 2022 Jun; 32(6):4090-4100. PubMed ID: 35044510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced CT radiomics for preoperative prediction of stage in epithelial ovarian cancer: a multicenter study.
    Leng Y; Kan A; Wang X; Li X; Xiao X; Wang Y; Liu L; Gong L
    BMC Cancer; 2024 Mar; 24(1):307. PubMed ID: 38448945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of Lung Metastases Originated From Different Primary Tumors Using Radiomics Features Based on CT Imaging.
    Shang H; Li J; Jiao T; Fang C; Li K; Yin D; Zeng Q
    Acad Radiol; 2023 Jan; 30(1):40-46. PubMed ID: 35577699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed tomography-based radiomics machine learning classifiers to differentiate type I and type II epithelial ovarian cancers.
    Li J; Li X; Ma J; Wang F; Cui S; Ye Z
    Eur Radiol; 2023 Jul; 33(7):5193-5204. PubMed ID: 36515713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of BOLD
    Deng Y; Pan L; Xing W; Zhou Z; Chen J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):1010-1017. PubMed ID: 34707012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.